HemoGenyx Pharmaceuticals Ltd.

Hemogenyx Pharmaceuticals is a publicly traded company developing new medicines and treatments for life-threatening diseases. Headquartered in London with research facilities in New York City, they are focused on bringing their cell therapies to patients in need. The company is developing a range of innovative product candidates, including HEMO-CAR-T, a chimeric antigen receptor T-cell therapy for acute myeloid leukemia, and CBR, a chimeric bait receptor platform that aims to prevent and combat infection by any known or emerging virus.

Hemogenyx Pharmaceuticals is driven by a mission to develop breakthrough therapies based on cutting-edge science, bring hope to patients with serious or life-threatening diseases, and treat life-threatening diseases to bring societal benefit. The company prioritizes integrity, courage, and ingenuity in all its endeavors. Their core values are reflected in their commitment to equal employment opportunities and their pursuit of groundbreaking medical solutions for patients worldwide.

Hemogenyx Pharmaceuticals offers a comprehensive benefits package to its employees, demonstrating their commitment to employee well-being. This includes equal employment opportunities for all applicants and employees, regardless of race, color, religion, sex, sexual orientation, age, gender identity, national origin, disability, or veteran status. The company also complies with all applicable national, state, and local laws governing nondiscrimination in employment, as well as work authorization and employment eligibility verification requirements.

Hemogenyx Pharmaceuticals is a publicly traded biopharmaceutical group dedicated to developing groundbreaking therapies for the treatment of life-threatening diseases, particularly blood cancers and viral infections. They strive to improve patient outcomes by creating innovative treatments, including cell-based immunotherapies like HEMO-CAR-T, bispecific monoclonal antibodies like CDX, and the Chimeric Bait Receptor (CBR) platform. Their passionate mission is to develop cutting-edge therapies based on breakthrough science, bring hope to patients, and ultimately achieve societal benefit through the treatment of these debilitating diseases.

Hemogenyx Pharmaceuticals cultivates a culture of integrity, courage, and ingenuity, fostering an environment where employees are encouraged to be open, honest, and entrepreneurial, taking calculated risks to push the boundaries of accepted theories and discover new solutions. The company prioritizes the benefit of patients, creating a passionate and dedicated team driven by a shared mission to develop breakthrough therapies for life-threatening diseases.

Hemogenyx Pharmaceuticals is committed to equal opportunities in employment, fostering a workplace where all individuals are respected and valued regardless of race, color, religion, sex, sexual orientation, age, gender identity, national origin, disability, or veteran status. The company complies with all applicable laws governing non-discrimination in employment and ensures all employees are legally eligible to work in the United States.